Share This

Public company info - Mediwelcome Healthcare Management & Technology Inc. , 02159.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Mediwelcome Healthcare Management & Technology Inc., 02159.HK - Company Profile
Chairman Shi Wei
Share Issued (share) 200,000,000
Par Currency Hong Kong Dollar
Par Value 1.0E-5
Industry Medical Equipment & Services
Corporate Profile Business Summary: The group is provider in the Integrated Healthcare Marketing Solutions Market. Performance for the year: For the years ended December 31, 2017, 2018 and 2019 and the six months ended June 30, 2019 and 2020, the group’s revenue was RMB258.9 million, RMB299.0 million, RMB427.2 million, RMB161.9 million and RMB138.7 million, respectively. For the corresponding periods, the group’s net profit/(loss) was RMB30.2 million, RMB39.7 million, RMB22.1 million, RMB2.1 million and RMB(4.0) million, respectively. Business Review The group is the largest provider in the Integrated Healthcare Marketing Solutions Market for CCVDs in China in terms of revenue in 2019, with a market share of 4.9% in the highly fragmented integrated healthcare marketing solutions industry for CCVDs, according to the CIC Report. The Integrated Healthcare Marketing Solutions Market for CCVDs in China was a RMB5.6 billion market in 2019, accounting for approximately 10.6% of the overall Integrated Healthcare Marketing Solutions Market in China. Founded in 2000, the group primarily provide (i) medical conference services, (ii) patient education and screening services, and (iii) marketing strategy and consulting services with the goal to address the unmet needs of each key constituent of the CCVD healthcare ecosystem, including physicians, patients, pharmaceutical companies, medical NGOs and hospitals, and to bridge the gaps among these constituents. In addition to providing integrated healthcare marketing solutions, the group also began to offer CRO services in late 2019 which primarily consist of patients’ recruitment and clinical data collection services, and internet hospital services which mainly provide online follow up consultation to the physicians’ existing patients and e-prescription service. the group have been committed to enabling better medical service and patient experience, improved disease control and lower the burden on the healthcare system in the long run. The group benefit from a high quality base of well-known customers and a physicians network, which have been crucial to the group’s historical success. the group have collaborated with some of China’s most esteemed medical NGOs, including the only medical association for CCVDs recognized by the CAST, which is the official organization for national professional societies in relation to science and technology in China. According to the CIC Report, among the global top ten pharmaceutical companies in terms of revenue in 2019, five were the group’s customers during the Track Record Period. Moreover, the group have developed a network of approximately 24,000 CCVD physicians as of June 30, 2020, among which over 70% worked for Grade 3 hospitals in China. All these physicians have participated in the group’s provision of integrated healthcare marketing solutions. the group have also established a medical advisory panel comprising four influential and well-recognized CCVD physicians to advise us on the group’s strategic direction and business expansion, including the development of internet hospital services and CRO services. The group have built various technology platforms to enhance the group’s integrated healthcare marketing solutions. To strengthen the group’s conference management capabilities, the group have launched the Conference+ App (醫會+) for users, i.e. medical NGOs and pharmaceutical companies, to submit onsite conference requests and monitor conference implementation. the group have also acquired Weiliandong, the owner of the Giraffe Platform which is a video conferencing and online education tool that enables hospitals to host or attend online medical conferences and access training videos recorded by physicians. To boost the group’s patient education and screening capabilities, the group developed and launched the Online Conference Assistant(線上會議助手), a WeChat mini-program that assists physicians in organizing and managing onsite patient education classes, as well as various WeChat public accounts where patients can find self-management support through watching educational videos, reading disease-related educational articles and conducting disease risk screening. Under the group’s internet hospital segment the group developed a mobile platform which offers online consultation and e-prescription services as of the Latest Practicable Date. THE GROUP’S SERVICES The group’s integrated healthcare marketing solutions consist of (i) medical conference services; (ii) patient education and screening services; and (iii) marketing strategy and consulting services. the group’s focus in terms of disease area was initially in stroke, and has since expanded to other CCVDs as well as other chronic diseases, such as diabetes and respiratory diseases. In addition to providing integrated healthcare marketing solutions, the group also began in late 2019 to offer CRO services which primarily consist of patients’ recruitment and clinical data collection services, and internet hospital services which mainly provide online follow up consultations to the physicians’ existing patients and e-prescription service. Prospects: In the next phase of the group’s development, the group plan to continue to expand and strengthen the group’s integrated healthcare marketing solutions by broadening the group’s customer base, disease area coverage and patient base. Moreover, the group plan to better serve the key constituents of the healthcare ecosystem in China by consolidating the physician resources and expertise, pharmaceutical company resources and patient base that the group have accumulated over almost 20 years and providing a comprehensive portfolio of value-added services by growing the group’s internet hospital platform and further expanding the group’s CRO services.

Information from the financial statements of listed companies

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.